Petar Jelinic

Petar Jelinic

Company: Merck

Job title: Director, Translational Oncology & Clinical Biomarkers


PARP Inhibitors and Anti-PD-(L)1 Immunotherapies: Biomarker Considerations in Mono vs Combination Therapies 3:30 pm

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.